Surgery Partners (SGRY) and The Competition Head-To-Head Review
Surgery Partners (NASDAQ: SGRY) is one of 15 publicly-traded companies in the “Hospitals, Clinics & Primary Care Services” industry, but how does it compare to its competitors? We will compare Surgery Partners to related companies based on the strength of its institutional ownership, valuation, profitability, analyst recommendations, risk, earnings and dividends.
Valuation & Earnings
This table compares Surgery Partners and its competitors top-line revenue, earnings per share (EPS) and valuation.
|Gross Revenue||Net Income||Price/Earnings Ratio|
|Surgery Partners||$1.15 billion||$9.45 million||-19.78|
|Surgery Partners Competitors||$1.06 billion||-$22.56 million||748.42|
This is a summary of current ratings and target prices for Surgery Partners and its competitors, as provided by MarketBeat.com.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
|Surgery Partners Competitors||57||326||509||9||2.52|
Surgery Partners currently has a consensus price target of $18.00, indicating a potential upside of 97.80%. As a group, “Hospitals, Clinics & Primary Care Services” companies have a potential upside of 20.93%. Given Surgery Partners’ higher probable upside, equities analysts clearly believe Surgery Partners is more favorable than its competitors.
Institutional & Insider Ownership
94.2% of Surgery Partners shares are held by institutional investors. Comparatively, 69.6% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by institutional investors. 7.6% of Surgery Partners shares are held by insiders. Comparatively, 10.4% of shares of all “Hospitals, Clinics & Primary Care Services” companies are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.
This table compares Surgery Partners and its competitors’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
|Surgery Partners Competitors||3.52%||3.52%||4.31%|
Volatility & Risk
Surgery Partners has a beta of 1.89, indicating that its share price is 89% more volatile than the S&P 500. Comparatively, Surgery Partners’ competitors have a beta of 1.47, indicating that their average share price is 47% more volatile than the S&P 500.
Surgery Partners competitors beat Surgery Partners on 8 of the 13 factors compared.
About Surgery Partners
Surgery Partners, Inc. is a healthcare services company. The Company operates in three lines of business across the United States: Surgical Facility Services, Ancillary Services and Optical Services. The Company’s Surgical Facility Services segment consists of the operation of ambulatory surgery centers (ASCs) and surgical hospitals, which include its anesthesia services. The Company’s surgical facilities primarily provide non-emergency surgical procedures across a range of specialties, which include gastrointestinal (GI), general surgery, ophthalmology, orthopedics and pain management. The Company’s Ancillary Services segment consists of a diagnostic laboratory, a specialty pharmacy and multi-specialty physician practices. The Company’s physician practices include its owned and operated physician practices pursuant to long-term management service agreements. The Company’s Optical Services segment consists of an optical laboratory, an optical products group purchasing organization.
Receive News & Ratings for Surgery Partners Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Surgery Partners Inc. and related companies with MarketBeat.com's FREE daily email newsletter.